Gewirtz AM - Search Results

1

c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus.

Kozuka T, Sugita M, Shetzline S, Gewirtz AM, Nakata Y. Kozuka T, et al. Among authors: gewirtz am. J Immunol. 2011 Dec 1;187(11):5974-82. doi: 10.4049/jimmunol.1100550. Epub 2011 Oct 28. J Immunol. 2011. PMID: 22039304 Free PMC article.

2

c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression.

Nakata Y, Shetzline S, Sakashita C, Kalota A, Rallapalli R, Rudnick SI, Zhang Y, Emerson SG, Gewirtz AM. Nakata Y, et al. Among authors: gewirtz am. Mol Cell Biol. 2007 Mar;27(6):2048-58. doi: 10.1128/MCB.01100-06. Epub 2007 Jan 22. Mol Cell Biol. 2007. PMID: 17242210 Free PMC article.

3

c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.

Jin S, Zhao H, Yi Y, Nakata Y, Kalota A, Gewirtz AM. Jin S, et al. Among authors: gewirtz am. J Clin Invest. 2010 Feb;120(2):593-606. doi: 10.1172/JCI38030. Epub 2010 Jan 19. J Clin Invest. 2010. PMID: 20093773 Free PMC article.

4

c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development.

Nakata Y, Brignier AC, Jin S, Shen Y, Rudnick SI, Sugita M, Gewirtz AM. Nakata Y, et al. Among authors: gewirtz am. Blood. 2010 Aug 26;116(8):1280-90. doi: 10.1182/blood-2009-05-223255. Epub 2010 May 18. Blood. 2010. PMID: 20484083 Free PMC article.

5

Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias.

Shetzline SE, Rallapalli R, Dowd KJ, Zou S, Nakata Y, Swider CR, Kalota A, Choi JK, Gewirtz AM. Shetzline SE, et al. Among authors: gewirtz am. Blood. 2004 Sep 15;104(6):1833-40. doi: 10.1182/blood-2003-10-3577. Epub 2004 Jun 8. Blood. 2004. PMID: 15187020 Free article.

6

Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.

Nakata Y, Kim TK, Shetzline S, Gewirtz AM. Nakata Y, et al. Among authors: gewirtz am. Crit Rev Eukaryot Gene Expr. 2005;15(2):163-82. doi: 10.1615/critreveukaryotgeneexpr.v15.i2.50. Crit Rev Eukaryot Gene Expr. 2005. PMID: 16022634 Review.

7

Progress in the development of nucleic acid therapeutics for cancer.

Kalota A, Shetzline SE, Gewirtz AM. Kalota A, et al. Among authors: gewirtz am. Cancer Biol Ther. 2004 Jan;3(1):4-12. doi: 10.4161/cbt.3.1.517. Epub 2004 Jan 18. Cancer Biol Ther. 2004. PMID: 14726654 Free article. Review.

8

Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression.

Sugita M, Kalota A, Gewirtz AM, Carroll M. Sugita M, et al. Among authors: gewirtz am. Leukemia. 2013 Apr;27(5):1207-10. doi: 10.1038/leu.2012.310. Epub 2012 Nov 6. Leukemia. 2013. PMID: 23183425 Free PMC article. No abstract available.

9

Integrin inhibition through Lyn-dependent cross talk from CXCR4 chemokine receptors in normal human CD34+ marrow cells.

Nakata Y, Tomkowicz B, Gewirtz AM, Ptasznik A. Nakata Y, et al. Among authors: gewirtz am. Blood. 2006 Jun 1;107(11):4234-9. doi: 10.1182/blood-2005-08-3343. Epub 2006 Feb 7. Blood. 2006. PMID: 16467205 Free PMC article.

10

Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells.

Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM. Ptasznik A, et al. Among authors: gewirtz am. Nat Med. 2004 Nov;10(11):1187-9. doi: 10.1038/nm1127. Epub 2004 Oct 24. Nat Med. 2004. PMID: 15502840 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters